Wang Ruihan, Wang Junqiu, Liu Tianyu, Wang Wei, Yin Shiqin, Peng Menglang, Zhang Lei
Department of Orthopedics, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
Capital Medical University China-Japan Friendship School of Clinical Medicine, Beijing, China.
Ann Med. 2025 Dec;57(1):2541092. doi: 10.1080/07853890.2025.2541092. Epub 2025 Aug 7.
BACKGROUND: The increasing participation in sports, driven by the popularity of physical activity and advancements in sports science, has led to a rise in sports injuries. Traditional treatments for sports injuries typically involve physical therapy and pharmacological interventions. However, drug therapy often suffers from low bioavailability, and analgesic and anti-inflammatory medications may also cause side effects such as gastrointestinal irritation and cardiovascular risks. To amplify the range of therapeutic options in the domain of sports injuries, microneedles (MNs) have emerged as a promising alternative. METHODS: A comprehensive review of English literature from the past two decades and more was performed across multiple databases, including PubMed, Embase, and Web of Science. The search utilized the keywords 'microneedle,' 'sports injury,' 'drug delivery,' etc. Original research articles, clinical studies, and reviews pertinent to the subject were included, while irrelevant and duplicate publications were excluded from the analysis. RESULTS: The diverse types and materials of MNs make them promising tools for treating sports injuries. These applications facilitate not only the targeted delivery of pharmaceuticals and biological materials but also enable continuous medical supervision through the assessment of subcutaneous metabolites. CONCLUSION: The application of MNs in the management of sports injuries holds significant promise for therapeutic interventions and medical monitoring, offering valuable insights for future innovation in sports science applications.
背景:在体育活动普及和运动科学进步的推动下,参与体育运动的人数不断增加,导致运动损伤增多。运动损伤的传统治疗通常包括物理治疗和药物干预。然而,药物治疗往往生物利用度低,止痛和抗炎药物也可能引起副作用,如胃肠道刺激和心血管风险。为了扩大运动损伤领域的治疗选择范围,微针已成为一种有前景的替代方法。 方法:对过去二十多年的英文文献进行了全面回顾,检索了多个数据库,包括PubMed、Embase和Web of Science。检索使用了“微针”“运动损伤”“药物递送”等关键词。纳入了与该主题相关的原始研究文章、临床研究和综述,分析中排除了无关和重复的出版物。 结果:微针的多种类型和材料使其成为治疗运动损伤的有前景的工具。这些应用不仅有助于药物和生物材料的靶向递送,还能通过评估皮下代谢物实现持续的医学监测。 结论:微针在运动损伤管理中的应用在治疗干预和医学监测方面具有重大前景,为运动科学应用的未来创新提供了有价值的见解。
Crit Rev Ther Drug Carrier Syst. 2025
Cochrane Database Syst Rev. 2020-1-9
Cochrane Database Syst Rev. 2021-4-19
Psychopharmacol Bull. 2024-7-8
Cochrane Database Syst Rev. 2017-12-22
Cochrane Database Syst Rev. 2018-1-16
Cochrane Database Syst Rev. 2016-12-27
Cochrane Database Syst Rev. 2018-2-6
Adv Healthc Mater. 2025-6-24
Nat Mater. 2025-4-3
Mikrochim Acta. 2025-2-24
Br J Sports Med. 2024-10-22
Biomater Sci. 2024-10-8